![Jonathan Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Williams
Directeur/Bestuurslid bij SB Drug Discovery Ltd.
Actieve functies van Jonathan Williams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SB Drug Discovery Ltd.
![]() SB Drug Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sygnature Discovery Ltd., SB Drug Discovery Ltd. is a British company that specializes in ion channel services. The company is based in Glasgow, UK. The company offers a portfolio of electrophysiology assays and customized cell line development capabilities to aid in ion channel drug discovery. The company's services include ion channel screening, receptor and enzyme studies, and custom cell line generation expertise. The company also provides a comprehensive panel of sodium (Nav) channel cell lines and assays, as well as HTS and selectivity profiling services to advance hit-to-lead campaigns. The company was founded in 2002. SB Drug Discovery was acquired by Sygnature Discovery Ltd. on January 17, 2023. | Directeur/Bestuurslid | - | - |
Loopbaan van Jonathan Williams
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SB Drug Discovery Ltd.
![]() SB Drug Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sygnature Discovery Ltd., SB Drug Discovery Ltd. is a British company that specializes in ion channel services. The company is based in Glasgow, UK. The company offers a portfolio of electrophysiology assays and customized cell line development capabilities to aid in ion channel drug discovery. The company's services include ion channel screening, receptor and enzyme studies, and custom cell line generation expertise. The company also provides a comprehensive panel of sodium (Nav) channel cell lines and assays, as well as HTS and selectivity profiling services to advance hit-to-lead campaigns. The company was founded in 2002. SB Drug Discovery was acquired by Sygnature Discovery Ltd. on January 17, 2023. | Commercial Services |
- Beurs
- Insiders
- Jonathan Williams
- Ervaring